
InfuSystem Holdings, Inc.
INFUAMEXHealthcareMedical - Devices
Previous close
$12.21
+$0.01 · +0.08%
INFU company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
82
Deep Value
Momentum
43
Neutral
Sentiment
59
Mixed
Risk resilience
50
Elevated Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteInfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Carrie A. Lachance
- Listed since
- Dec 27, 2007
- Employees
- 467
Market position
Day range
Current $12.21
52-week range
Current $12.21
- Open
- $12.165
- Previous close
- $12.20
- Volume
- 97.07K
- 0.48× average
- Average volume
- 202.06K
- Average daily volume
- Market cap
- 246.42M USD
- Beta
- 1.46
- Market reference 1
- 50-day average
- $10.1468
- +20.33% above average
- 200-day average
- $9.4154
- +29.68% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 185.54M USD
- P/E (TTM)
- 29.05×
- P/B (TTM)
- 4.16×
- P/S (TTM)
- 1.72×
- EV / EBITDA
- 7.36×
- Earnings yield
- 3.58%
- Free cash flow yield
- 8.48%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 57.45%
- Operating margin
- 9.26%
- Net margin
- 5.96%
- Return on equity
- 11.56%
- Return on assets
- 6.59%
- Return on invested capital
- 9.25%
Financial health
- Debt / equity
- 0.39×
- Current ratio
- 1.8×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 143.44M USD | 134.86M USD | 125.79M USD | 109.91M USD | 102.38M USD |
| Cost of goods sold | 63.14M USD | 64.46M USD | 62.68M USD | 49.35M USD | 43.85M USD |
| Gross profit | 80.3M USD | 70.4M USD | 63.11M USD | 60.56M USD | 58.54M USD |
| Selling, general, and administrative | 67.46M USD | 62.52M USD | 58.03M USD | 56.41M USD | 51.45M USD |
| Operating expenses | 68.38M USD | 63.51M USD | 59.02M USD | 58.91M USD | 55.72M USD |
| Interest expense | 1.3M USD | 1.78M USD | 2.17M USD | 1.4M USD | 1.38M USD |
| Depreciation and amortization | 13.29M USD | 12.5M USD | 12.51M USD | 13.36M USD | 14.63M USD |
| Operating income | 11.92M USD | 6.89M USD | 4.09M USD | 1.65M USD | 2.82M USD |
| Net income | 6.63M USD | 2.35M USD | 872K USD | 18K USD | 1.42M USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 73%
- 8 beats, 3 misses, 0 met estimates
- Average EPS surprise
- +30.03%
- 11 comparable reports
- Latest EPS result
- 0.15
- Estimate 0.11 · Beat by 42.86%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
4 ratingsLimited analyst sample: 4 ratings. Interpret the distribution with caution.
Recent analyst actions
INFU news
INFU peers
ETFs holding INFU
Funds reporting this stock among their holdings, ordered by reported position size.
Avantis U.S. Small Cap Value ETFAVUV8.84M0.03%31.27B USD0.25%$126.45—
iShares Russell 2000 ETFIWM5.25M0.01%81.62B USD0.19%$299.96—
Vanguard Morningstar Total Stock Market ETFVTI5M0.00%2.3T USD0.03%$378.24—
iShares Russell 2000 Growth ETFIWO2.21M0.01%15.16B USD0.24%$387.37—
Vanguard Extended Market ETFVXF2.09M0.00%93.7B USD0.05%$245.53—
Vanguard Russell 2000 ETFVTWO994.72K0.01%17.4B USD0.06%$121.25—
iShares Micro-Cap ETFIWC816.89K0.05%1.53B USD0.60%$198.39—
Dimensional - US Small Cap ETFDFAS812.91K0.01%15.92B USD0.26%$83.02—
Avantis U.S. Small Cap Value ETFAVUV- Market value
- 8.84M
- Weight
- 0.03%
- AUM
- 31.27B USD
- Expense ratio
- 0.25%
- Price / 1D
- $126.45—
iShares Russell 2000 ETFIWM- Market value
- 5.25M
- Weight
- 0.01%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96—
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 5M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24—
iShares Russell 2000 Growth ETFIWO- Market value
- 2.21M
- Weight
- 0.01%
- AUM
- 15.16B USD
- Expense ratio
- 0.24%
- Price / 1D
- $387.37—
Vanguard Extended Market ETFVXF- Market value
- 2.09M
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53—
Vanguard Russell 2000 ETFVTWO- Market value
- 994.72K
- Weight
- 0.01%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25—
iShares Micro-Cap ETFIWC- Market value
- 816.89K
- Weight
- 0.05%
- AUM
- 1.53B USD
- Expense ratio
- 0.60%
- Price / 1D
- $198.39—
Dimensional - US Small Cap ETFDFAS- Market value
- 812.91K
- Weight
- 0.01%
- AUM
- 15.92B USD
- Expense ratio
- 0.26%
- Price / 1D
- $83.02—
Continue in GoAI
Research INFUresearch.disclaimer











